In Brief: Medamicus
This article was originally published in The Gray Sheet
Medamicus: Delays rollout of the Lumax uroflow system, an enhancement to its Lumax Fiber Optic Cystometry System designed to diagnose patients suffering from benign prostatic hyperplasia ("The Gray Sheet" April 29, I&W-9), "in order to overcome unforeseen complexities in the development of software for the product," the firm says. Release of the system, initially expected in June, is now slated for the middle of July...
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.